Altimmune
ALT
Altimmune (ALT) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Leerink Partners | Initiated Coverage | Outperform | $10.00 | Jun 22, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $25.00 | May 18, 2026 |
| Citizens | Maintained | Market Outperform | $11.00 from $14.00 | May 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 from $12.00 | Mar 16, 2026 |
| B. Riley Securities | Maintained | Buy | $13.00 from $18.00 | Mar 6, 2026 |
| Citizens | Maintained | Market Outperform | $14.00 from $15.00 | Nov 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Oct 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Oct 10, 2025 |
| B. Riley Securities | Maintained | Buy | $18.00 from $20.00 | Aug 13, 2025 |
| UBS | Maintained | Buy | $24.00 from $26.00 | Aug 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Aug 13, 2025 |
| JMP Securities | Maintained | Market Outperform | $15.00 from $25.00 | Jul 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Jun 27, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Apr 3, 2025 |
| Citizens Capital Markets | Maintained | Market Outperform | $25.00 | Apr 2, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Mar 18, 2025 |
| Citizens Capital Markets | Maintained | Market Outperform | $25.00 | Mar 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Mar 3, 2025 |
| William Blair | Initiated Coverage | Market Perform | — | Feb 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Feb 5, 2025 |
Frequently asked questions
What is the latest analyst rating on ALT?
On Jun 22, 2026, Leerink Partners initiated coverage of Altimmune at Outperform with a price target of $10.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.